BLMH meets yearly guidance with Q3 results. Following a strong quarterly earnings report, Bloom Health Partners (CSE: BLMH) CEO Andrew Morton will be speaking at this year's Health Benefits Nation Conference in Orlando.
BLMH’s Q3 results saw the company reach yearly guidance a full quarter ahead of schedule. Fiscal Q3 revenue brought the companies YTD earnings to $24.9 million, just shy of the company’s 2022 guidance of $25 million.
Given these earning, BLMH.c is trading at an extreme undervaluation, with a current P/S ratio of 0.354. The market average for company’s in BLMH’s sector is around 4, meaning the company should be trading at a valuation of roughly $100 million.
If BLMH continues its current performance this next fiscal quarter, the company is well on track to smash its yearly guidance. At that point, its undervaluation will be undeniable and SP will see a steep rise IMO.
BLMH.c is currently trading at $.185, valued at $8.82 million.
https://ceo.ca/@newsfile/bloom-health-partners-ceo-to-speak-at-health-benefits